Answers are grounded in this paper and cite their sources.
The cell‐mediated immune response of animals to a lethal syngeneic tumor was investigated by inoculating C57BL mice with Lewis lung carcinoma (3LL) cells T lymphocytes, obtained from the enlarged spleens of the tumor‐bearing mice were found to be cytotoxic to 3LL target cells in vitro . However, we found that such spleen cells enhanced tumor growth in vivo when mice were injected with a mixture of spleen cells and tumor cells. Removal of T lymphocytes by treatment of the spleen cells with anti‐Θ serum plus complement reduced the enhancement of tumor growth. Hence, the tumor enhancing cells, like the cytotoxic cells, appeared to be T lymphocytes. Removal of T lymphocytes from normal mice by adult thymectomy before tumor inoculation led to a reduction in the number of tumor metastases. Thus, enhancing T lymphocytes appear to exist in normal as well as in tumor‐bearing mice. Investigation of this mechanism of tumor enhancement suggested that the enhancing T lymphocytes act as suppressor T cells inhibiting natural immune resistance to tumor growth.
No takes yet. Share an insight, caveat, or question.
Treves et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: